Drug intelligence / Profile preview

ergocalciferol + cholecalciferol

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

A combination of two forms of vitamin D - ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3). Both are fat-soluble vitamins that help the body absorb calcium and phosphorus, which are essential for building and maintaining strong bones. Ergocalciferol is plant-derived while cholecalciferol is animal-derived and more closely resembles the form naturally produced in human skin when exposed to sunlight. This combination may be used in specific clinical situations such as for dialysis patients who have both vitamin D deficiency and calcitriol hormone insufficiency.

Other names: Vitamin D2 + Vitamin D3

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on ergocalciferol + cholecalciferol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ergocalciferol + cholecalciferol.

Explore the full profile